Andrew Mc Kibben
About Andrew Mc Kibben
Andrew Mc Kibben serves as the Vice President at Mirum Pharmaceuticals, where he has worked since 2019. He holds an M.B.A. from the University of California, Berkeley, and has extensive experience in finance and corporate development across several pharmaceutical companies.
Work at Mirum Pharmaceuticals
Andrew Mc Kibben has served as Vice President at Mirum Pharmaceuticals since 2019. His role involves overseeing various strategic initiatives within the company, contributing to its growth and development in the biopharmaceutical sector. Based in the San Francisco Bay Area, he has been instrumental in guiding the company through key projects and operational strategies.
Education and Expertise
Andrew Mc Kibben earned a Master of Business Administration (M.B.A.) from the Haas School of Business at the University of California, Berkeley. He also holds a degree in Economics and French Literature from Pomona College. His educational background provides a strong foundation for his expertise in finance, corporate development, and strategic operations within the pharmaceutical industry.
Background in Finance and Corporate Development
Prior to his current role, Andrew Mc Kibben held various positions in finance and corporate development. He worked at Tobira Therapeutics, where he progressed from Associate Director to Director and then Senior Director of Finance & Corporate Development between 2014 and 2016. His experience includes strategic financial planning and corporate strategy development.
Experience at Allergan
At Allergan, Andrew Mc Kibben worked as Executive Director in two capacities: Global Program Lead from 2017 to 2019 and Strategy and Lifecycle Planning for the Liver Therapeutic Area from 2016 to 2017. His roles involved managing global programs and strategic planning, contributing to the company's initiatives in the pharmaceutical market.
Previous Roles in Consulting and Pharmaceuticals
Before his tenure at Allergan, Andrew Mc Kibben worked at Deloitte Consulting as a Consultant in Strategy & Operations from 2005 to 2010. He also held a position at Onyx Pharmaceuticals as Senior Manager of Strategy & Strategic Asset Management from 2011 to 2014. These roles provided him with a diverse background in strategic consulting and asset management within the pharmaceutical industry.